Candel Therapeutics raised $28.7M Series B venture round, led by Paul Manning.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
| Private | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$181.7M
Top Valuation
-
Candel Therapeutics raised $28.7M in a Series B round.
The round was announced on 01/04/19.
The round was led by Paul Manning.